Share This Author
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- D. Klionsky, K. Abdelmohsen, S. Zughaier
- BiologyAutophagy
- 18 April 2012
TLDR
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
- N. Khan, F. Afaq, M. Saleem, N. Ahmad, H. Mukhtar
- BiologyCancer research
- 1 March 2006
TLDR
Tea polyphenols for health promotion.
- N. Khan, H. Mukhtar
- MedicineLife sciences
- 26 July 2007
Tea polyphenols: prevention of cancer and optimizing health.
- H. Mukhtar, N. Ahmad
- MedicineThe American journal of clinical nutrition
- 1 June 2000
TLDR
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.
- N. Ahmad, D. Feyes, A. Nieminen, R. Agarwal, H. Mukhtar
- Biology, MedicineJournal of the National Cancer Institute
- 17 December 1997
TLDR
Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
- N. Ahmad, S. Gupta, H. Mukhtar
- BiologyArchives of biochemistry and biophysics
- 15 April 2000
TLDR
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
- Sanjay Gupta, K. Hastak, N. Ahmad, J. Lewin, H. Mukhtar
- Biology, MedicineProceedings of the National Academy of Sciences…
- 14 August 2001
TLDR
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea.
- T. Haqqi, D. Anthony, H. Mukhtar
- Biology, MedicineProceedings of the National Academy of Sciences…
- 13 April 1999
TLDR
Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol…
- S. Katiyar, F. Afaq, K. Azizuddin, H. Mukhtar
- Biology, ChemistryToxicology and applied pharmacology
- 15 October 2001
TLDR
Cannabinoid receptor as a novel target for the treatment of prostate cancer.
- S. Sarfaraz, F. Afaq, V. Adhami, H. Mukhtar
- Biology, MedicineCancer research
- 1 March 2005
TLDR
...
...